Toxicogenomics

 Toxicogenomics

 

Toxicogenomics is related to pharmacogenomics, combining toxicology, genetics, molecular biology, and environmental health to elucidate the response of living organisms to stressful environments or toxic agents. Likewise, new drug candidates can be screened through a combination of gene expression profiling and toxicol-ogy to understand gene response and possibly predict safety (Furness, 2002). Genomic techniques utilized include gene expression level profiling and single-nucleotide polymorphism analysis of the genetic variation of individuals generally employing micro-array technology. Toxicogenomic studies are corre-lated to adverse toxicological effects in clinical trials so that suitable biomarkers for these adverse effects can be developed. Using such methods, it would then theoretically possible to test an individual patient forhis or her susceptibility to these adverse effects before administering a drug. Patients that would show the marker for an adverse effect would be switched to a different drug. At this time however, the field is in its infancy.

Comments

Post a Comment

Popular posts from this blog

Adaptive Immune System - Immunological Principles of Vaccines

Image
  The Adaptive Immune System   The adaptive immune system is involved in elimina-tion of pathogens in the late phase of infection and in the generation of immunological memory. It consists of B- andsystem can be divided into humoral and cell-mediated immunity (CMI) (Fig. 4 and Table 3). The humoral response results in antibody formation (but contains cell-mediated events, Fig. 4A,B); CMI results in the generation of cytotoxic cells (Fig. 4A,B). The actionof antibodies and T-cells is dependent on accessory factors, some of which are mentioned in Table 3. In general, after infection with a pathogen or a protective vaccine, both humoral and cellular responses are generated. This indicates that both are needed for efficient protection. The balance between humoral and cellular responses, however, can differ widely between pathogens and is dependent on how the pathogen is presented to the adaptive immune system by APCs. This may have consequences for the design of a particular vaccine (see s
Read more

“Omics” Enabling Technology: Bioinformatics

Image
  “Omics” Enabling Technology: Bioinformatics Structural genomics, functional genomics, proteomics, and other “omic” technologies have generated an enormous volume of genetic and biochemical data to store. The entire encoded human DNA sequence alone requires computer storage of approximately 10 9  bits of information: the equivalent of a thousand 500-page books! GenBank (managed by the National Center for Biotechnology Information, NCBI, of the National Institutes of Health), the European Molecular Biology Laboratory (EMBL), and the DNA Data Bank of Japan (DDBJ) are three of the many centers worldwide that collaborate on collecting DNA sequences. These databanks, (both public and private) store tens of millions of sequences (Martin et al., 2007). Metabolic databases and other collections of biochemical and bioactivity data add to the complexity and wealth of information (Olah and Oprea, 2007). Once stored, analyzing the volumes of data, (i.e., comparing and relating information from va
Read more

Proteomics, Structural Proteomics, and Functional Proteomics - “Omics” Technologies

Image
  Proteomics, Structural Proteomics, and Functional Proteomics Functional genomics research will provide an unprece-dented information resource for the study of biochemical pathways at the molecular level. Certainly a large number of the  ~ 25,000 genes identified in sequencing the human genome will be shown to be functionally important in various disease states (see druggable genome discussion above). This will result in the identification of a vast array of proteins implicated as playing pivotal roles in disease processes (Evans, 2003). These key identified proteins will serve as potential new sites for therapeutic intervention (Fig. 1). The research area called proteomics seeks to define the function and correlate that with expression profiles of all proteins encoded within an organism’s genome or “proteome” (Edwards et al., 2000; Kreider, 2001; Voshol et al., 2007). The  ~ 25,000 human genes can produce 100,000 proteins. The number, type and concentration may vary depending on cell
Read more